1.
2.
Parkinsonism Relat Disord
; 111: 105445, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37201326
RESUMO
No blood biomarkers which can identify Alzheimer's disease pathology in Lewy body disease (LBD) have ever been established. We showed that the plasma amyloid-ß (Aß) 1-42/Aß1-40 ratio was significantly decreased in patients with Aß+ LBD compared with those with Aß- LBD and it might be a useful biomarker.
Assuntos
Doença de Alzheimer , Doença por Corpos de Lewy , Humanos , Doença de Alzheimer/patologia , Doença por Corpos de Lewy/patologia , Proteínas tau , Peptídeos beta-Amiloides , Biomarcadores , Comorbidade
3.
4.
